The importance of both
CYP2C19
and
CYP2B6
germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.
Helsby, N.A.; Yong, M.; van Kan, M.; de Zoysa, J.R.; Burns, K.E.
- 期刊名称British Journal of Clinical Pharmacology
- 作者Helsby, N.A.; Yong, M.; van Kan, M.; de Zoysa, J.R.; Burns, K.E.
- 印刷ISSN0306-5251
- 文件大小642.14KB
- 发表时间2019-06-19
- DOI10.1111/bcp.14031